The ability of tebentafusp to induce potent anti-tumor activity based on T-cell-mediated killing of exclusively gp100+ and HLA-A*02:01+ melanoma cell lines was demonstrated previously [37,38]. The gene discussed is HLA-A; the disease is melanoma.